Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma
Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma
Recruiting · NCT06712459 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma | Transformed Splenic Marginal Zone Lymphoma | Recruiting | Not stated | 2026-01-16 | NCT06712459 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| International Extranodal Lymphoma Study Group (IELSG) | 11 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University | New York | United States | 154 |
| Fondazione IRCCS Policlinico San Matteo | Pavia | Italy | 75 |
| Hospital Clínic de Barcelona | Barcelona | Spain | 55 |
| Hôpital Saint Louis | Paris | France | 5 |
| Oncology Institute of Southern Switzerland | Bellinzona | Switzerland | 6 |
| University Hospitals Dorset | Bournemouth | United Kingdom | 3 |
| Universitz Hospitals Leuven | Leuven | Belgium | 1 |